GCLC Antibody, Biotin conjugated

Code CSB-PA009321LD01HU
Size US$299 How to order?
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name Rabbit anti-Homo sapiens (Human) GCLC Polyclonal antibody
Uniprot No. P48506
Target Names GCLC
Alternative Names EC antibody; Gamma ECS antibody; Gamma glutamylcysteine synthetase antibody; Gamma-ECS antibody; Gamma-glutamylcysteine synthetase antibody; GCL antibody; Gclc antibody; GCS antibody; GCS heavy chain antibody; GLCL antibody; GLCLC antibody; Glutamate cysteine ligase catalytic subunit antibody; Glutamate--cysteine ligase catalytic subunit antibody; GSH1_HUMAN antibody
Raised in Rabbit
Species Reactivity Human
Immunogen Recombinant Human Glutamate--cysteine ligase catalytic subunit protein (78-236AA)
Immunogen Species Homo sapiens (Human)
Conjugate Biotin
Clonality Polyclonal
Isotype IgG
Purification Method >95%, Protein G purified
Concentration It differs from different batches. Please contact us to confirm it.
Buffer Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form Liquid
Tested Applications ELISA
Protocols ELISA Protocol
Troubleshooting and FAQs Antibody FAQs
Storage Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Gene References into Functions
  1. Study found that the frequency of C/T polymorphism genotype of GCLC gene in patients with pulmonary tuberculosis is 36.4%. PMID: 29023060
  2. the present study demonstrated that cells transformed by chronic exposure to 3MC exhibited inhibition of GSH biosynthesis by suppression of GCL protein expression and reduction of cysteine availability, which may subsequently render cells vulnerable to oxidative stress. PMID: 29039508
  3. Glutathione biosynthesis during the lipopolysaccharide-induced inflammatory response in THP-1 macrophages is tightly and differentially regulated via GCLC and GCLM subunits of glutamate cysteine ligase. PMID: 28993271
  4. High expression of GCLC in tumor tissue may be a potential predictor of treatment failure. PMID: 29474642
  5. gamma-GCS has a role in chemo- and radio-resistance of human hepatocellular carcinoma cells PMID: 29549912
  6. The findings indicate that expression of the transcription factor NRF2 and its effector GCL are both profoundly deregulated in endometriotic lesions towards increased growth and fibrogenetic processes. PMID: 28457937
  7. Taken together, our findings provide evidence that G9a protects head and neck squamous cell carcinomas (HNSCC)cells against chemotherapy by increasing the synthesis of GSH, and imply G9a as a promising target for overcoming cisplatin resistance in HNSCC PMID: 28265008
  8. A panel consisting of IGFBP1, KIM1, GCLC and GSTM1 genes could be used in combination for early screening of CKDu, whereas these genes in addition with FN1, IGFBP3 and KLK1 could be used to monitor progression of CKDu. The regulation of these genes has to be studied on larger populations to validate their efficiency for further clinical use. PMID: 28103909
  9. High GCLC expression is associated with chemotherapy resistance in breast cancer. PMID: 26894974
  10. Knockdown of CD44 reduced the protein level of xCT, a cystine transporter, and increased oxidative stress. However, an increase in GSH was also observed and was associated with enhanced chemoresistance in CD44-knockdown cells. Increased GSH was mediated by the Nrf2/AP-1-induced upregulation of GCLC, a subunit of the enzyme catalyzing GSH synthesis PMID: 28185919
  11. GCLC polymorphisms correlated with brain GSH and Glu levels in psychosis. PMID: 27069063
  12. NQO1 and GCLC were both functionally sufficient to autonomously confer a tamoxifen-resistant metabolic phenotype, characterized by i) increased mitochondrial biogenesis, ii) increased ATP production and iii) reduced glutathione levels. PMID: 28411284
  13. (i) melatonin counteracted UVR-induced alterations in the ATP synthesis and reduced free radical formation; (ii) melatonin induced the translocation of Nrf2 transcription factor from the cytosol into the nucleus resulting in, (iii) melatonin enhanced gene expression of phase-2 antioxidative enzymes including gamma-glutamylcysteine synthetase (gamma-GCS), heme oxygenase-1 (HO-1), and NADPH: quinone dehydrogenase-1 (NQO1... PMID: 27117941
  14. Glutaminolysis is activated in ES2 and OVCAR3, though ES2 exclusively synthesizes amino acids and GSH. ES2 cells are more resistant to carboplatin than OVCAR3 and the abrogation of GSH production by BSO sensitizes ES2 to carboplatin. HNF1beta regulates the expression of GCLC, but not GCLM, and consequently GSH production in ES2 PMID: 26520442
  15. miR-433 targets both catalytic (GCLc) and regulatory (GCLm) subunits of GCL. PMID: 25353619
  16. Data suggest expression of hepatocyte GCLC and GCLM can be regulated by dietary component; alpha-lipoic acid, a vitamin B complex nutrient, protects against oxidative stress/cytotoxicity induced by cadmium via restoration of GCLC and GCLM expression. PMID: 26365678
  17. Cigarette smoke-induced hypermethylation of the GCLC promoter is related to the initiation and progression of COPD. PMID: 26087411
  18. GCLC and GSS were expressed at higher levels in colon cancer tissue, as compared with normal mucosa. PMID: 26059756
  19. The Kaplan-Meier analysis shows that rs3736729 on GCLC presents a significant association with disease-free survival and overall survival. PMID: 23443115
  20. H2S upregulates GCLC and GSH and inhibits IL-1beta levels, which may be what mediates the beneficial effects of H2S-rich compounds in mitigating the pathogenesis of metabolic syndrome and atherosclerosis PMID: 24665821
  21. the CYP1A1 (rs2606345, rs4646903, rs1048943), GCLC, AGT, and AGTR1 genes was associated with pleuritis, empyema, acute respiratory distress syndrome, all PC and acute respiratory failure (ARF). PMID: 24068433
  22. A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. PMID: 22610501
  23. 1,25 (OH) vitamin D significantly upregulated expression of GCLC and GR and lowered secretion of IL-8 and MCP-1 in high-glucose exposed U937 monocytes. PMID: 23770363
  24. Polymorphisms in GCLC, GSTM1, GSTT1, and GSTP1 genes associated with metabolism of glutathione act on cystic fibrosis severity. PMID: 23758905
  25. Genistein up-regulated HO-1 and Glutamate-Cysteine Ligase expression through the EKR1/2 and PKC /Nrf2 pathways during oxidative stress. PMID: 23255485
  26. Data suggest that microRNA/mRNA pairs in hsa-miR-140-3p/RAD51AP1/, hsa-miR-145/E2F3, hsa-miR-139-5p/TOP2A, and hsa-miR-133a/GCLC were correlated with ovarian tumorigenesis. PMID: 22452920
  27. rs761142 in GCLC was found to be associated with reduced GCLC mRNA expression and with SMX-induced hypersensitivity in HIV/AIDS patients. PMID: 22824134
  28. Data show for the first time that GCLC may serve a dual role, as a surrogate marker for cellular redox state as well as malignant potential of melanoma cells. PMID: 22249522
  29. insulin increased GCLc promoter activity, which required a prerequisite increase or decrease in medium glucose PMID: 21871559
  30. The functional SNPs CYBA -675 T --> A and GCLC rs17883901, probably associated with cellular redox imbalances, modulate the risk for renal disease in the studied population of type 1 diabetes patients PMID: 21962117
  31. high-risk glutamate-cysteine ligase catalytic subunit GAG trinucleotide repeat genotypes lead to alterations of plasma thiols levels that reflect a dysregulation of redox control PMID: 20673128
  32. Results suggest that GAG polymorphism affects GCLC expression via translation, and thus may be associated with altered risk for GSH-related diseases and toxicities. PMID: 21444626
  33. the single nucleotide polymorphism (SNP) -129C/T (rs17883901) in glutamate-cysteine ligase catalytic subunit (GCLC) and SNPs I128T (rs3816873) and Q95H (rs61733139) in microsomal triglyceride transfer protein (MTTP) in nonalcoholic fatty liver disease PMID: 21438662
  34. SNPs not associated with self-reported depression PMID: 21277635
  35. The impacts of four clinical missense mutations on GCLC enzymatic function in vivo and in vitro, was evaluated. PMID: 21657237
  36. GCLC is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells. PMID: 21555518
  37. Posttranslational modification and regulation of glutamate-cysteine ligase by the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal. PMID: 20970495
  38. SNPs not associted with schizophrenia in Japanese individuals PMID: 21105962
  39. These results provide evidence that interaction of the two variations can efficiently impair GCLC expression and thus suggest its involvement in the pathogenesis of diseases related to GSH metabolism. PMID: 21156206
  40. Data show that activation of the PPARgamma/PGC-1alpha pathway may protect against COPD progression by upregulating gamma-GCS and relieving oxidative stress. PMID: 20732852
  41. An ethnic-specific polymorphism in the catalytic subunit of glutamate-cysteine ligase impairs the production of glutathione intermediates in vitro. PMID: 20655259
  42. PD98059 and erythromycin could block AP-1 transduction pathway, but increase the synthesis of gamma-GCS induced by 4-hydroxynonenal in bronchial epithelial cells. PMID: 19567187
  43. Regulation of GCL(cat) by MYCN accounts for the survival of neuroblastoma cells against oxidative damage; GCL should be considered a potential therapeutic target for the treatment of MYCN-amplified neuroblastoma. PMID: 20180881
  44. Polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes may be associated with non-alcoholic liver disease progression. PMID: 19817962
  45. Expression of the gamma-glutamylcysteine synthetase heavy subunit gene is inducible by certain nonsteroidal anti-inflammatory drugs (e.g., indomethacin) in colon cancer cells. PMID: 11820781
  46. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes PMID: 11844594
  47. Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells. PMID: 11972604
  48. identification of a variant antioxidant response element in the promoter region PMID: 12070177
  49. redox-sensitive elements directing expression of the glutamate cysteine ligase in CYP2E1-expressing cells are present in the ARE4 distal portion of the 5'-flanking region, perhaps a reflection of metabolic adaptation to CYP2E1-generated oxidative stress. PMID: 12500194
  50. A new gamma-GCSH mutation from gamma-GCS deficiency, a C>T missense mutation at nucleotide 379, encodes a predicted Arg127Cys amino acid change. The mutated amino acid lies within a cleft on the protein surface of gamma-GCSH, containing Cys249. PMID: 12663448

Show More

Hide All

Involvement in disease Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)
Protein Families Glutamate--cysteine ligase type 3 family
Database Links

HGNC: 4311

OMIM: 230450

KEGG: hsa:2729

STRING: 9606.ENSP00000229416

UniGene: Hs.654465

Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
7505 Fannin St. Ste 610-312, Houston, TX 77054, USA
Join Us with

Subscribe newsletter

Leave a message

© 2007-2022 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1